Correlation of adiponectin gene polymorphisms with coronary artery disease and plaque progression

Journal of Shanghai Jiaotong University (Medical Science)

Volumn 29, Issue 4, 2009, Pages 435-439

  Zhang, Xian Ling ^a   Peng, Wen Hui ^a   Lu, Lin ^a   Wu, Li Qun ^a   Gu, Gang ^a   Wang, Ling Jie ^a   Yan, Xiao Xiang ^a   Chen, Qiu Jing ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adiponectin; Coronary artery disease; Plaque progression; Single nucleotide polymorphisms

Indexed keywords

EID: 84856985975     PISSN: 16748115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin [J]. Circulation, 1999, 100(25): 2473-2476.
2. Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macropha-ges [J]. Circulation, 2001, 103(8): 1057-1063.
3. Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis [J]. J Biol Chem, 2002, 277(40): 37487-37491.
4. Francke S, Manraj M, Lacquemant C, et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27 [J]. Hum Mol Genet, 2001, 10(24): 2751-2765.
5. Vionnet N, Hani EH, Dupont S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome lq21-q24 [J]. Am J Hum Genet, 2000, 67(6): 1470-1480.
6. Hoefle G, Muendlein A, Saely CH, et al. The -11377 C > G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men [J]. Thromb Haemost, 2007, 97(3): 451-457.
7. Gable DR, Matin J, Whittall R, et al. Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects [J]. Ann Hum Genet, 2007, 71(Pt4): 453-466.
8. Lacquemant C, Froguel P, Lobbens S, et al. The adiponectin gene SNP + 45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus [J]. Diabet Med, 2004, 21(7): 776-781.
9. Bacci S, Menzaghi C, Ercolino T, et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients [J]. Diabetes Care, 2004, 27(8): 2015-2020.
10. Qi L, Li T, Rimm E, et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men [J]. Diabetes, 2005, 54(5): 1607-1610.
11. Pischon T, Pai JK, Manson JE, et al. Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women [J]. Obesity (Silver Spring), 2007, 15(8): 2051-2060.
12. Maahs DM, Ogden LG, Kinney GL, et al. Low plasma adiponectin levels predict progression of coronary artery calcification [J]. Circulation, 2005, 111(6): 747-753.
13. Liang KW, Sheu WH, Lee WL, et al. Decreased circulating protective adiponectin level is associated with angiographic coronary disease progression in patients with angina pectoris [J]. Int J Cardiol, 2008, 129(1): 76-80.
14. Waters D, Craven TE, Lesperance J. Prognostic significance of progression of coronary atherosclerosis [J]. Circulation, 1993, 87(4): 1067-1075.
15. Azen SP, Mack WJ, Cashin-Hemphill L, et al. Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study [J]. Circulation, 1996, 93(1): 34-41.
16. Buchwald H, Marts JP, Fitch LL, et al. Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group [J]. JAMA, 1992, 268(11): 1429-1433.
17. Berry C, L'Allier PL, Gregoire J, et al. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression [J]. Circulation, 2007, 115(14): 1851-1857.
18. Tso AW, Sham PC, Wat NM, et al. Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study [J]. Diabetologia, 2006, 49(8): 1806-1815.
19. Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls [J]. Horm Metab Res, 2000, 32(2): 47-50.
20. Yamauchi T, Kamon J, Waki H, et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atheroscle-rosis [J]. J Biol Chem, 2003, 278(4): 2461-2468.
21. Okamoto Y, Kihara S, Ouchi N, et al. Adiponectin reduces athero-sclerosis in apolipoprotein E-deficient mice [J]. Circulation, 2002, 106(22): 2767-2770.
22. Li CJ, Sun HW, Zhu FL, et al. Local adiponectin treatment reduces atherosclerotic plaque size in rabbits [J]. J Endocrinol, 2007, 193(1): 137-145.
23. Hermann TS, Li W, Dominguez H, et al. Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes [J]. J Clin Endocrinol Metab, 2006, 91(3): 1001-1008.